Table 2.
Final epithelial lining fluid population pharmacokinetic model parameters for ceftazidime and avibactam
| Drug | Parameter | Median | 5th percentile | 95th percentile | CV % | 
|---|---|---|---|---|---|
| Ceftazidime | EMAX, mg/l | 45.4 ± 12% | 30.9 | 66.5 | 24 | 
| KM, mg/l | 71.7 ± 22% | 18.8 | 273.3 | 97 | |
| RESMELF | 0.101 | 0 | 0 | 0 | |
| Avibactam | EPR (1 mg/l) | 0.472 ± 11% | 0.172 | 1.298 | 68 | 
| POW | 0.860 ± 5% | 0.588 | 1.259 | 23 | |
| RESMELF | 0.117 | 0 | 0 | 0 | 
CV coefficient of variation, ELF epithelial lining fluid, EPR (1 mg/l) ELF penetration ratio at plasma concentration of 1 mg/l, EMAX maximal concentration, KM Michaelis–Menten constant, POW power term, RESMELF residual noise (median) for ELF, KELF rate constant for ELF